Operating at the intersection of healthcare, technology, and business, Zara has architected omnichannel infrastructure and growth engines, influencing more than $1B in enterprise value for global healthcare leaders. Her clients include global conglomerates such as Pfizer, AstraZeneca, Takeda, and Novartis, as well as 20+ high-growth biotech and digital health startups. Over her career, she has spearheaded the launch of 50+ successful products across the U.S. and international markets in the pharma, biotech, diagnostics, medtech, and digital health sectors.

With a foundation in Biology, Digital Media, Artificial Intelligence, and Health & Wellness from elite institutions such as MIT, Harvard Medical School, and Edinburgh Business School, Zara de-risks innovation for boards and founders by aligning breakthrough science to stakeholder and market needs, accelerating the path from clinical validation to category-defining market leadership. 

Driven by the belief that even the most brilliant science requires a powerful narrative to achieve real-world impact, she ensures that life-changing innovations and therapies achieve the adoption necessary to transform patient outcomes.